• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » David Blumenthal named 2017 recipient of the health services research prize

David Blumenthal named 2017 recipient of the health services research prize

May 22, 2017
CenterWatch Staff

David Blumenthal has been named the 2017 recipient of the William B. Graham Prize for Health Services Research.

Dr. Blumenthal has served the public throughout his distinguished career in medicine, health services research, and leadership in the domains of health policy, health information technology innovation, and the organization and financing of medical care. His contributions in research and leadership have influenced healthcare management, practice and policy over the past three decades.

The Prize, which has been awarded since 1986, recognizes the contributions of health services researchers who have had a significant impact on the health of the public in one of three primary focus areas: health services management, health policy development, and healthcare delivery. The contributions of Dr. Blumenthal reflect all three of these areas. An independent committee of past winners, distinguished academics, and internationally recognized researchers selects the recipient each year.

“I am deeply humbled by this honor, and in accepting I am cognizant of my debt to all my colleagues—past and present—at the Massachusetts General Hospital, Harvard University, the Office of the National Coordinator, and the Commonwealth Fund, as well as colleagues and peers all over the world,” said Dr. Blumenthal. “Without their support and collaboration, my work would have been much less fulfilling and productive.

“Next year, the Commonwealth Fund will celebrate its centennial and reflect on 100 years of working toward the goal of a high-performing, affordable, and equitable health system for all Americans. Receiving the William B. Graham prize, which was previously bestowed on my predecessor at the Fund, Karen Davis, is a wonderful way to mark this important anniversary. Many thanks to The Baxter International Foundation and the Association of University Programs in Health Administration for administering this program, for recognizing notable efforts to promote research and evidence in health care, and for this much appreciated award.”

David Blumenthal, M.D., MPP, is president of The Commonwealth Fund, a private, nonprofit foundation that supports independent research on health policy reform and a high performance health system. He is the former Samuel O. Thier Professor of Medicine at Harvard Medical School and Chief Health Information and Innovation Officer at Partners Healthcare System in Boston. From 2009 to 2011, Dr. Blumenthal served as the National Coordinator for Health Information Technology, with the charge to build an interoperable, private, and secure nationwide health information system and to support the widespread, meaningful use of health IT. Previously, he was a practicing primary care physician, director of the Institute for Health Policy, and professor of medicine and health policy at Massachusetts General Hospital/Partners Healthcare System and Harvard Medical School. Dr. Blumenthal is the author of more than 250 books and scholarly publications, including Heart of Power: Health and Politics in the Oval Office.

The Prize is awarded by The Baxter International Foundation and the Association of University Programs in Health Administration (AUPHA).

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing